
Nihon Kohden Corp (6849) - Product Pipeline Analysis, 2022 Update
Description
Summary
Nihon Kohden Corp (Nihon Kohden) develops, manufactures and commercializes medical electronic equipment and other systems to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators and hematology analyzers. These products find applications in health management, home medical care, nursing and basic medical research. The company carries out its business operations through branch offices and direct sales personnel in Japan and through subsidiaries and distributors across the world. Nihon Kohden is headquartered in Tokyo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Nihon Kohden Corp (Nihon Kohden) develops, manufactures and commercializes medical electronic equipment and other systems to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators and hematology analyzers. These products find applications in health management, home medical care, nursing and basic medical research. The company carries out its business operations through branch offices and direct sales personnel in Japan and through subsidiaries and distributors across the world. Nihon Kohden is headquartered in Tokyo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Nihon Kohden Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
34 Pages
- Nihon Kohden Corp Company Overview
- Nihon Kohden Corp Company Snapshot
- Nihon Kohden Corp Pipeline Products and Ongoing Clinical Trials Overview
- Nihon Kohden Corp – Pipeline Analysis Overview
- Business Description
- Nihon Kohden Corp - Key Facts
- Nihon Kohden Corp - Major Products and Services
- Nihon Kohden Corp Pipeline Products by Development Stage
- Nihon Kohden Corp Ongoing Clinical Trials by Trial Status
- Nihon Kohden Corp Pipeline Products Overview
- Aneterrace
- Aneterrace Product Overview
- HeartMate
- HeartMate Product Overview
- MONITORLYZER
- MONITORLYZER Product Overview
- OLV-4202 Pulse Oximeter
- OLV-4202 Pulse Oximeter Product Overview
- OLV-4202 Pulse Oximeter Clinical Trial
- PINT
- PINT Product Overview
- RADARCIRC
- RADARCIRC Product Overview
- Nihon Kohden Corp - Key Competitors
- Nihon Kohden Corp - Key Employees
- Nihon Kohden Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Nihon Kohden Corp, Recent Developments
- May 13, 2022: Nihon Kohden announces FY2021 consolidated financial results
- May 13, 2022: Nihon Kohden Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
- Feb 02, 2022: Nihon Kohden announces FY2021 third quarter consolidated financial results
- Feb 02, 2022: Nihon Kohden Announces Revisions to its Forecast for Financial Results and Dividend
- Nov 08, 2021: Nihon Kohden announces FY2021 second quarter consolidated financial results
- Nov 08, 2021: Nihon Kohden Announces a Revision to its Forecast for Financial Results
- Sep 14, 2021: Nihon Kohden announces a revision to its forecast for financial results for the first half of the fiscal year ending March 31, 2022
- Aug 11, 2021: Nihon Kohden America and CrowdStrike partner to implement best in class protection against advanced cyber threats in rapidly changing healthcare environments
- Aug 04, 2021: Nihon Kohden Announces Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2022
- Aug 04, 2021: Nihon Kohden Announces a Revision to its Forecast for Financial Results
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Nihon Kohden Corp Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Nihon Kohden Corp Pipeline Products by Equipment Type
- Table 3: Nihon Kohden Corp Pipeline Products by Indication
- Table 4: Nihon Kohden Corp, Key Facts
- Table 5: Nihon Kohden Corp, Major Products and Services
- Table 6: Nihon Kohden Corp Number of Pipeline Products by Development Stage
- Table 7: Nihon Kohden Corp Pipeline Products Summary by Development Stage
- Table 8: Nihon Kohden Corp Ongoing Clinical Trials by Trial Status
- Table 9: Nihon Kohden Corp Ongoing Clinical Trials Summary
- Table 10: Aneterrace - Product Status
- Table 11: Aneterrace - Product Description
- Table 12: HeartMate - Product Status
- Table 13: HeartMate - Product Description
- Table 14: MONITORLYZER - Product Status
- Table 15: MONITORLYZER - Product Description
- Table 16: OLV-4202 Pulse Oximeter - Product Status
- Table 17: OLV-4202 Pulse Oximeter - Product Description
- Table 18: OLV-4202 Pulse Oximeter - Accuracy of Pulse Oximeters with Profound Hypoxia NIHO 14
- Table 19: OLV-4202 Pulse Oximeter - Determination of SpO2 and PR Accuracy Specifications at Rest Accuracy of Pulse Oximeters with Profound Hypoxia Pulse Oximeter Accuracy Evaluation Protocol
- Table 20: PINT - Product Status
- Table 21: PINT - Product Description
- Table 22: RADARCIRC - Product Status
- Table 23: RADARCIRC - Product Description
- Table 24: Nihon Kohden Corp, Key Employees
- Table 25: Nihon Kohden Corp, Other Locations
- Table 26: Nihon Kohden Corp, Subsidiaries
- Table 27: Glossary
- List of Figures
- Figure 1: Nihon Kohden Corp Pipeline Products by Equipment Type
- Figure 2: Nihon Kohden Corp Pipeline Products by Development Stage
- Figure 3: Nihon Kohden Corp Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.